Cell Therapeutics


Cell Therapeutics Reviews

5 Reviews
5 Reviews
Rating Trends

Recommend to a friend
Approve of CEO
Cell Therapeutics President, CEO, and Director James A. Bianco
James A. Bianco
4 Ratings
  • 1 person found this helpful  

    Great Company - unfortunate luck

    • Comp & Benefits
    • Work/Life Balance
    • Senior Management
    • Culture & Values
    • Career Opportunities
    Former Employee - Anonymous Employee in Seattle, WA
    Former Employee - Anonymous Employee in Seattle, WA

    I worked at Cell Therapeutics full-time


    Excellent talent & people! Deep pipleline of potential products


    Needs to catch a break

    Advice to ManagementAdvice

    Keep hiring top talent

    Positive Outlook
    Approves of CEO

Cell Therapeutics Awards & Accolades

Let us know if we're missing any workplace or industry recognition – Add an award

Additional Info

Unlock Profile
Website www.ctibiopharma.com
Headquarters Seattle, WA
Size 50 to 149 Employees
Founded Unknown
Type Company - Public (CTIC)
Industry Biotech & Pharmaceuticals
Revenue $25 to $50 million (USD) per year

Cell Therapeutics (CTI) is a toxic avenger. The firm creates more effective and less toxic treatments for various forms of cancer. CTI is developing a number of cancer-fighting compounds, including pixantrone, a treatment for non-Hodgkin's lymphoma and other tumorous cancers, and Opaxio (paclitaxel poliglumex) for non-small cell lung and ovarian cancers. The company's Systems Medicine subsidiary is working on a potential sarcoma-fighter called brostallicin. CTI no longer markets any commercial products and instead focuses on research and development projects.

Work at Cell Therapeutics? Share Your Experiences

Cell Therapeutics

Click to Rate